As part of the nationwide trend of precision medicine, Baylor’s Human Genome Sequencing Center will assist in sequencing the DNA of 69 different genes that may influence how patients react to certain drugs. Such pharmacogenomic findings could then be placed in patients’ medical records, providing early warnings to clinicians about which drugs may present problems for patients.
“This collaboration is a wonderful example of how a partnership between a genome center and a premier clinical group can speed the translation of valuable genomic tests into useful advances in patient care,” said Richard Gibbs, PhD, director of the Human Genome Sequencing Center at Baylor.
More articles on genomics:
Geisinger opens Precision Health Center
What do genomics mean for the individual patient?
Rare Genomics Institute announces new director and CEO
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
